Vanda Pharmaceuticals Inc. Vanda Nasdaq VNDA today announced that the company will participate at the following upcoming investor conferences in November 2026
Why Is Vanda Pharmaceuticals Inc. (VNDA) Stock Down Today?
Updated Nov 16, 2026 8:30 PM ET · Prev Close $3.99
Primary Move Catalyst & Conviction
65% Signal ConvictionPharmaceuticals & Therapeutics sector moving together
This appears to be a sector-wide move. The Pharmaceuticals & Therapeutics sector is down 3.6% on average.
Market & Sector Relative Strength
VNDA lagging the S&P 500 by -2.91%Options Flow & Execution Desk
Bullish Flow · P/C 0.36Unlock 3 Unusual VNDA Options Sweep Strikes
See exact institutional strike concentrations, volume-to-OI ratios, and multi-leg payoff blueprints with Tradestie Pro.
Recent VNDA Catalyst Headlines
Verified WireVanda Pharmaceuticals Inc VNDA posted 69.8 million in Q3 2026 revenue on surging Fanapt demand and early Nereus sales, while narrowing its quarterly net loss ahead of key launches.
Moby summary of Vanda Pharmaceuticals Inc.'s Q3 2026 earnings call
Revenue surged 24 year over year, driven by Fanapt growth and NEREUS launch momentum.
1–3 Day Expected Range & Key Level
45% Follow-ThroughWatch for breakdown below $3.77
Technical Regime (VNDA)
BEARISH MA TREND1-Year Historical Move Analogs
48 EventsSessions in the past year where VNDA moved >3.0% down:
Retail & Crowd Sentiment
Very BullishStockTwits is filled with bullish sentiments towards $VNDA, with traders expressing confidence in the support levels.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; Hetlioz for the treatment of Non-24-Hour Sleep-Wake Disorde...
Get Instant VNDA Catalyst Alerts
Receive an email alert when VNDA triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversVNDA Session & Catalyst FAQ
Why is VNDA stock down today?
This appears to be a sector-wide move. The Pharmaceuticals & Therapeutics sector is down 3.6% on average.
Is VNDA stock a buy or sell right now?
Today's session carries a 65% catalyst conviction score on 0.38x relative volume (low participation). Our multi-factor model currently rates VNDA as HOLD. Review full valuation, quality, and timing signals on the VNDA Buy or Sell Decision Brief →
What is VNDA's intrinsic value and expected trading range?
At $3.79, VNDA's modeled 1-to-3 session range is $3.66 – $3.85, with a key inflection level at $3.59 (support). Compare current price against multi-year cash flow projections in the VNDA Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for VNDA?
RSI at 40.0 reflects soft below-midline momentum. VNDA trades at $3.79 relative to its 20-day SMA ($3.95) and 50-day SMA ($4.46), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.